Nrn1-KO Mouse
Common Name
Nrn1-KO
제품 ID
S-KO-18254
Backgroud
C57BL/6JCya
품종 계통계통 ID
KOCMP-68404-Nrn1-B6J-VB
상태
이 마우스 계통을 논문에서 사용할 경우, “Nrn1-KO Mouse (카탈로그 번호 S-KO-18254)은 Cyagen에서 구입하였습니다.”라고 명시해 주시기 바랍니다.
구매 가능한 제품 종류
연령
Genotype
성별
수량
표준 제공 조건은 최소 3마리의 이형접합(heterozygous) 보균자를 보장합니다. 동형접합(homozygous) 보균자 및/또는 특정 성별에 대한 브리딩 서비스도 제공됩니다.
기본 정보
품종 계통
Nrn1-KO
품종 계통계통 ID
KOCMP-68404-Nrn1-B6J-VB
유전자명
제품 ID
S-KO-18254
유전자 별칭
Nrn, Cpg15, 0710008J23Rik
배경
C57BL/6JCya
NCBI ID
변형 내용
Conventional knockout
염색체
Chr 13
Phenotype
Datasheet
적용 분야
--
품종 계통 설명
Ensembl 전사체 ID
ENSMUST00000037623
NCBI 전사체 ID
NM_153529
타겟 영역
Exon 2
유효 영역 크기
~0.1 kb
유전자 연구 개요
Nrn1, also known as Neuritin 1, is a neurotrophic factor crucial for neurodevelopment and synaptic plasticity. It is involved in neural cell survival, differentiation, axonal and dendritic growth, as well as synapse formation and maturation. The expression of Nrn1 can be enhanced by BDNF, and it is suggested to activate the insulin receptor (IR) pathway to promote the transcription of CACNA1C [3]. Nrn1 has been associated with multiple biological processes and diseases, highlighting its overall biological importance.
In melanoma, Nrn1 was found to interact directly with the cleaved intracellular domain of Notch1 and Notch3, reducing the expression of Hes1, which in turn affects the sequestration of JAK and STAT3 in a phosphorylation complex, ultimately influencing the oncogenic STAT3 signaling [1].
In schizophrenia, genetic and neuroimaging approaches have shown an association between Nrn1 and early-onset schizophrenia. Different haplotypes of Nrn1 were associated with early-onset, and its genetic epistasis with BDNF and CACNA1C affected the clinical presentation of the disorder via neuroanatomical changes [2,3].
In optic nerve crush rats, Nrn1 overexpression attenuated retinal ganglion cell apoptosis, promoted axonal regeneration, and improved visual function by activating the Akt1 and Stat3 pathways and inhibiting the mitochondrial apoptotic pathway [4].
In esophageal cancer, Nrn1 suppresses cancer growth both in vitro and in vivo by inhibiting PI3K-Akt-mTOR signaling, and its methylation is a novel synthetic lethal marker for related inhibitors [5].
In diacetylmorphine-induced neuronal apoptosis, NEFL was found to regulate the Nrn1-mediated mitochondrial pathway to promote apoptosis [6]. Also, in schizophrenia, NRN1 genetic variability and methylation changes may serve as biomarkers for cognitive remediation therapy response [7].
And in Alzheimer's disease, NRN1 provided dendritic spine resilience against amyloid-β and blocked amyloid-β-induced neuronal hyperexcitability in cultured neurons [8].
In conclusion, Nrn1 plays essential roles in neural-related biological processes, including neural cell survival, synapse formation, and synaptic plasticity. Through model-based research, its significance in various disease areas such as melanoma, schizophrenia, optic nerve injury, esophageal cancer, drug-induced neuronal apoptosis, and Alzheimer's disease has been revealed. These findings contribute to a better understanding of the underlying mechanisms of these diseases and may provide potential therapeutic targets.
References:
1. Devitt, Lucia, Westphal, Dana, Pieger, Katharina, Bosserhoff, Anja Katrin, Kuphal, Silke. 2024. NRN1 interacts with Notch to increase oncogenic STAT3 signaling in melanoma. In Cell communication and signaling : CCS, 22, 256. doi:10.1186/s12964-024-01632-8. https://pubmed.ncbi.nlm.nih.gov/38705997/
2. Almodóvar-Payá, Carmen, Guardiola-Ripoll, Maria, Giralt-López, Maria, Pomarol-Clotet, Edith, Fatjó-Vilas, Mar. 2022. NRN1 Gene as a Potential Marker of Early-Onset Schizophrenia: Evidence from Genetic and Neuroimaging Approaches. In International journal of molecular sciences, 23, . doi:10.3390/ijms23137456. https://pubmed.ncbi.nlm.nih.gov/35806464/
3. Almodóvar-Payá, Carmen, Guardiola-Ripoll, Maria, Giralt-López, Maria, Pomarol-Clotet, Edith, Fatjó-Vilas, Mar. 2024. NRN1 epistasis with BDNF and CACNA1C: mediation effects on symptom severity through neuroanatomical changes in schizophrenia. In Brain structure & function, 229, 1299-1315. doi:10.1007/s00429-024-02793-5. https://pubmed.ncbi.nlm.nih.gov/38720004/
4. Huang, Tingting, Li, He, Zhang, Shoumei, Wang, Dong, Xu, Jiajun. 2020. Nrn1 Overexpression Attenuates Retinal Ganglion Cell Apoptosis, Promotes Axonal Regeneration, and Improves Visual Function Following Optic Nerve Crush in Rats. In Journal of molecular neuroscience : MN, 71, 66-79. doi:10.1007/s12031-020-01627-3. https://pubmed.ncbi.nlm.nih.gov/32607759/
5. Du, Wushuang, Gao, Aiai, Herman, James G, Jiao, Shunchang, Guo, Mingzhou. 2021. Methylation of NRN1 is a novel synthetic lethal marker of PI3K-Akt-mTOR and ATR inhibitors in esophageal cancer. In Cancer science, 112, 2870-2883. doi:10.1111/cas.14917. https://pubmed.ncbi.nlm.nih.gov/33931924/
6. Zhu, Sensen, Su, Liping, Zhuang, Mengjie, Yang, Long, Pu, Hongwei. 2024. NEFL Modulates NRN1-Mediated Mitochondrial Pathway to Promote Diacetylmorphine-Induced Neuronal Apoptosis. In Molecular neurobiology, , . doi:10.1007/s12035-024-04629-z. https://pubmed.ncbi.nlm.nih.gov/39557800/
7. Almodóvar-Payá, Carmen, París-Gómez, Irene, Latorre-Guardia, Mariona, Penadés, Rafael, Fatjó-Vilas, Mar. 2024. NRN1 genetic variability and methylation changes as biomarkers for cognitive remediation therapy response in schizophrenia. In Progress in neuro-psychopharmacology & biological psychiatry, 136, 111175. doi:10.1016/j.pnpbp.2024.111175. https://pubmed.ncbi.nlm.nih.gov/39426559/
8. Hurst, Cheyenne, Pugh, Derian A, Abreha, Measho H, Herskowitz, Jeremy H, Seyfried, Nicholas T. 2023. Integrated Proteomics to Understand the Role of Neuritin (NRN1) as a Mediator of Cognitive Resilience to Alzheimer's Disease. In Molecular & cellular proteomics : MCP, 22, 100542. doi:10.1016/j.mcpro.2023.100542. https://pubmed.ncbi.nlm.nih.gov/37024090/
품질 관리 기준
정자 검사
동결 보존 전: 정자 농도 측정 및 정자 생존율 평가.
동결 보존 후: 각 배치에서 동결 보존된 정자 바이알 1개를 선택하여 체외수정(in vitro fertilization)에 사용합니다.
Environmental Standards:
SPFAvailable Region:
GlobalSource:
Cyagen문의하기
맞춤형 동물 모델 관련 상담을 위해 Cyagen 전문가와 연락해 보세요. 아래 양식을 작성하여 상담을 시작하거나 견적을 요청하시기 바랍니다.
Cyagen은 고객님의 개인정보를 소중히 여깁니다. 최신 제품, 서비스 및 인사이트를 안내드리고자 합니다. 고객님의 수신 설정은 다음과 같습니다:
해당 커뮤니케이션은 언제든지 수신 거부하실 수 있습니다. 수신 거부 방법 및 데이터 보호에 대한 자세한 내용은 개인정보처리방침을 참고해 주시기 바랍니다.
아래 버튼을 클릭함으로써, 요청하신 콘텐츠 제공을 위해 본 양식을 통해 제출된 개인정보를 Cyagen이 저장 및 처리하는 데 동의하게 됩니다.
